logo
calendar4 Noyabr 2019
view43
Main language:Russian

CLINICAL EFFICIENCY OF VIRENTE® PREPARATION

Field of Science:
pdf

5dbfc7b3ee8b8.pdf

PDF

Oʻzbekiston farmatsevtik xabarnomasi

Oʻzbekiston farmatsevtik xabarnomasi

Publish Articlesee more

ARTICLE ANNOTATION

quote
The article presents the results of studies of the efficacy and tolerability of VIRENTE® 1.0 mg tablets manufactured by FE LLC “NOBEL PHARMSANOAT”, Uzbekistan, compared with ENKAVIR® 1.0 mg tablets manufactured by Jeil Pharmaceutical Co., Ltd., Korea, in patients viral hepatitis B. According to the results of the obtained data, conclusions were drawn about the comparability of the action of these drugs.

AUTHORS

I.Samatova

НИИ Вирусологии МЗ РУз

SH.Gaziyeva

Ташкентская медицинская академия

Tags

# ўткир гепатит В# сурункали гепатит В# энтекавир# острый гепатит В# хронический гепатит В# acute hepatitis B# chronic hepatitis B# entecavir

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

ROI:

https://eroi.uz/11.0014/A1119-0015

DOI:

Not Available

References

1. Воробьев П.А., Чуланов В.П., Телегина И.В., Борисенко О.В. Анализ воспринимаемой ценности при реализации стратегии лечения больных хроническим гепатитом В препаратом энтекавира. Инфекционные болезни. 2011;9(3):5-12.

2. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther. 2011;34(10):1145-58. doi: 10.1111/j.1365-2036.2011.04869.x.

3. Dooley JS, Look ASF, Burroughs AK, Heath- cote EJ, editors. Sherlok's diseases of the liver and biliary system. 12 th edition. WILEY-BLACK- WELL; 2011.771 p.

4. Hadziyannis SJ, Papatheodoridis GV. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis. 2006;26(2):130-41.

5. Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology. 2000;31(5):1037-44.

6. Manesis EK. HBeAg-negative chronic hepatitis B: from obscurity to prominence. J Hepatol. 2006;45(3):343-6.

7. Niederau C. Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit. World J Gastroenterol. 2014;20(33):11595-617. doi: 10.3748/wjg.v20.i33.11595.

8. Santantonio TA, Fasano M. Chronic hepatitis B: advances in treatment. World J Hepatol. 2014;6(5):284-92. doi: 10.4254/wjh.v6.i5.284.

9. World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. MARCH 2015. World Health Organization; 2015. 134 p. Available from: www.who. int/about/licensing/copyright_form/en/in- dex.html

10. Zhou Y, Holmes EC. Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J Mol Evol. 2007;65(2):197-205.